Clinical Trial

Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2019 (before its estimated March 2020 completion). Its status may not reflect the trial's current state.
Summary
The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2016-10-11; most recent amendment 2021-11-03.
Status change: Recruiting → Completed 2021-11-03
Status change: Not Yet Recruiting → Recruiting 2017-01-17
Trial Details
NCT Number NCT02932007
Lead Sponsor University of South Florida
Conditions Atrial Fibrillation
Enrollment 40 participants
Start Date 2017-03-28
Primary Completion 2020-03 (estimated)
Study Completion 2020-09 (estimated)
Updated on ClinicalTrials.gov 2019-08-19